Anne S. Boewe
Homburg, SL 66421, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Combining Temozolomide with a Selective CK2 Inhibitor Results in Anti-Tumour Effects in Glioblastoma Cell Lines.
Journal: Molecules (Basel, Switzerland)
Published: November 26, 2025
CK2 regulates somatostatin expression in pancreatic delta cells.
Journal: Islets
Published: June 06, 2025
CK2 activity is crucial for proper glucagon expression.
Journal: Diabetologia
Published: August 03, 2023
C-Myc/H19/miR-29b axis downregulates nerve/glial (NG)2 expression in glioblastoma multiforme.
Journal: Molecular therapy. Nucleic acids
Published: June 01, 2023
Protein Kinase CK2 Contributes to Glucose Homeostasis by Targeting Fructose-1,6-Bisphosphatase 1.
Journal: International journal of molecular sciences
Published: October 26, 2022
Hypoxia-induced downregulation of microRNA-186-5p in endothelial cells promotes non-small cell lung cancer angiogenesis by upregulating protein kinase C alpha.
Journal: Molecular therapy. Nucleic acids
Published: August 20, 2022
Adipose tissue-derived microvascular fragments promote lymphangiogenesis in a murine lymphedema model.
Journal: Journal of tissue engineering
Published: April 05, 2022
Inhibition of CK2 Reduces NG2 Expression in Juvenile Angiofibroma.
Journal: Biomedicines
Published: January 11, 2022
Targeting Pancreatic Islet NLRP3 Improves Islet Graft Revascularization.
Journal: Diabetes
Published: September 21, 2021
CK2 Activity Mediates the Aggressive Molecular Signature of Glioblastoma Multiforme by Inducing Nerve/Glial Antigen (NG)2 Expression.
Journal: Cancers
Published: March 11, 2021
Showing 1-12 of 12
Last Updated: 09/26/2026